Polarization deepens in drug industry

Gone are the times when mid- and small-sized drug firms earned profits easily by producing generics, which refer to drugs that have the same ingredients and effects as the original brand name drugs. They are now on the brink of a precipice.

According to data released yesterday by Yakup.com, a Korean information provider on pharmaceutical business, the combined sales of 38 drug firms listed o...